Beijing Tong Ren Tang Chinese Medicine Company Limited

BJTRFOTCHealthcare● Active

$0.64

$-0.01(-1.26%)

Market Cap$535911420

P/E Ratio—

52W High$0.6484

52W Low$0.6402

Avg Volume203.2

Open$0.65

Beta0.35

Overview

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BJTRF · earnings · updated Jun 9, 2026

Latest Earnings

Q3 FY2025Report Date: Aug 22, 2025

EPS Actual

$0.04

Revenue

$0.10B

Fiscal Period

Q3 FY2025

FY ends December

Report Date

Aug 22, 2025

After Market Close

BJTRF reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 7, 2026	—	—	—	—	—	—
◌ Q3 FY2026	Aug 7, 2026	—	—	—	—	—	—
— Q3 FY2025	Aug 22, 2025	—	$0.04	—	$0.10B	—	—
◌ Q2 FY2025	Jun 6, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 28, 2025	—	—	—	—	—	—
— Q3 FY2024	Aug 30, 2024	—	$0.02	—	$0.04B	—	—
— Q2 FY2024	Jun 7, 2024	—	$0.02	—	$0.04B	—	—
— Q1 FY2024	Mar 14, 2024	—	$0.02	—	$0.05B	—	—

Q3 FY2026

Aug 7, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2026

Aug 7, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 22, 2025

EPS Actual

$0.04

EPS Est.

—

EPS Surpr.

—

Revenue

$0.10B

Q2 FY2025

Jun 6, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 30, 2024

EPS Actual

$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.04B

Q2 FY2024

Jun 7, 2024

EPS Actual

$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.04B

Q1 FY2024

Mar 14, 2024

EPS Actual

$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.05B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2025	$0.00	$0.00	$0.00	0
Q2 FY2025	$0.00	$0.00	$0.00	0

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2025	$0.0B	$0.0B	$0.0B	1
Q2 FY2025	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2025	Aug 22, 2025	—	$0.65	$0.65	+0.00%
— Q3 FY2024	Aug 30, 2024	—	$0.65	$0.65	+0.00%
— Q2 FY2024	Jun 7, 2024	—	$0.65	$0.65	+0.00%
— Q1 FY2024	Mar 14, 2024	—	$1.49	$1.49	+0.00%
— Q4 FY2023	Dec 30, 2023	—	$1.49	$1.49	+0.00%
— Q2 FY2023	Jun 29, 2023	—	$1.49	$1.49	+0.00%
— Q1 FY2023	Mar 31, 2023	—	$1.49	$1.49	+0.00%
— Q4 FY2022	Dec 30, 2022	—	$1.49	$1.49	+0.00%

Q3 FY2025+0.00%

Report Date

Aug 22, 2025

EPS Beat/Miss

—

Price Before

$0.65

Price After

$0.65

Q3 FY2024+0.00%

Report Date

Aug 30, 2024

EPS Beat/Miss

—

Price Before

$0.65

Price After

$0.65

Q2 FY2024+0.00%

Report Date

Jun 7, 2024

EPS Beat/Miss

—

Price Before

$0.65

Price After

$0.65

Q1 FY2024+0.00%

Report Date

Mar 14, 2024

EPS Beat/Miss

—

Price Before

$1.49

Price After

$1.49

Q4 FY2023+0.00%

Report Date

Dec 30, 2023

EPS Beat/Miss

—

Price Before

$1.49

Price After

$1.49

Q2 FY2023+0.00%

Report Date

Jun 29, 2023

EPS Beat/Miss

—

Price Before

$1.49

Price After

$1.49

Q1 FY2023+0.00%

Report Date

Mar 31, 2023

EPS Beat/Miss

—

Price Before

$1.49

Price After

$1.49

Q4 FY2022+0.00%

Report Date

Dec 30, 2022

EPS Beat/Miss

—

Price Before

$1.49

Price After

$1.49

Beat Rate0 / 8 quarters

Largest Move+0.00% (Q3 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) most recently reported earnings on August 22, 2025 for Q3 FY2025, posting EPS of $0.04 (in line with the analyst consensus of —). The next BJTRF earnings date is expected around September 1, 2026.

Each quarter, investors track BJTRF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BJTRF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BJTRF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BJTRF earnings · 4 questions

Beijing Tong Ren Tang Chinese Medicine Company Limited's next earnings report is expected around September 1, 2026. BJTRF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BJTRF historically reports after market close (AMC).

BJTRF earnings datewhen is BJTRF earningsBJTRF next earnings datewhen does BJTRF report earningsBJTRF earnings calendar

▸ Source: FMP · Beijing Tong Ren Tang Chinese Medicine Company Limited SEC filings · US GAAP · Beijing Tong Ren Tang Chinese Medicine Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026